66 related articles for article (PubMed ID: 15684819)
1. MxA and PKR expression in chronic hepatitis C.
Giannelli G; Guadagnino G; Dentico P; Antonelli G; Antonaci S
J Interferon Cytokine Res; 2004 Nov; 24(11):659-63. PubMed ID: 15684819
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
MacQuillan GC; de Boer WB; Platten MA; McCaul KA; Reed WD; Jeffrey GP; Allan JE
J Med Virol; 2002 Oct; 68(2):197-205. PubMed ID: 12210408
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.
Hamdi N; El-Akel W; El-Serafy M; Esmat G; Sarrazin C; Abdelaziz AI
Intervirology; 2012; 55(3):210-8. PubMed ID: 21597279
[TBL] [Abstract][Full Text] [Related]
4. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
Shaker O; Ahmed A; Doss W; Abdel-Hamid M
J Viral Hepat; 2010 Nov; 17(11):794-9. PubMed ID: 20002306
[TBL] [Abstract][Full Text] [Related]
5. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
Asahina Y; Izumi N; Umeda N; Hosokawa T; Ueda K; Doi F; Tsuchiya K; Nakanishi H; Matsunaga K; Kitamura T; Kurosaki M; Uchihara M; Higaki M; Miyake S
J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
[TBL] [Abstract][Full Text] [Related]
8. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.
Gerotto M; Dal Pero F; Bortoletto G; Realdon S; Ferrari A; Boccato S; Alberti A
Antivir Ther; 2004 Oct; 9(5):763-70. PubMed ID: 15535414
[TBL] [Abstract][Full Text] [Related]
9. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
[TBL] [Abstract][Full Text] [Related]
10. Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses.
Mihm S; Monazahian M; Grethe S; Meier V; Thomssen R; Ramadori G
J Med Virol; 2000 May; 61(1):29-36. PubMed ID: 10745229
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis C--treatment of untreated (naive) patients].
Duvnjak M; Pavić T; Tomasić V; Lerotić I; Virović L
Acta Med Croatica; 2005; 59(5):453-61. PubMed ID: 16381243
[TBL] [Abstract][Full Text] [Related]
12. Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with peginterferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C.
Malone DC; Tran TT; Poordad FF
J Manag Care Pharm; 2005 Oct; 11(8):687-94. PubMed ID: 16194133
[TBL] [Abstract][Full Text] [Related]
13. Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection.
Sagir A; Heintges T; Akyazi Z; Oette M; Erhardt A; Häussinger D
Liver Int; 2007 Sep; 27(7):954-9. PubMed ID: 17696934
[TBL] [Abstract][Full Text] [Related]
14. Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C.
Cheng JC; Yeh YJ; Huang YH; Liang KH; Chang ML; Lin CY; Yeh CT
J Viral Hepat; 2012 Feb; 19(2):e154-62. PubMed ID: 22239513
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
Napoli N; Giannelli G; Parisi CV; Antonaci A; Maddalena G; Antonaci S
New Microbiol; 2005 Jan; 28(1):13-21. PubMed ID: 15782622
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.
MacQuillan GC; Mamotte C; Reed WD; Jeffrey GP; Allan JE
J Med Virol; 2003 Jun; 70(2):219-27. PubMed ID: 12696108
[TBL] [Abstract][Full Text] [Related]
17. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Bronowicki JP; Ouzan D; Asselah T; Desmorat H; Zarski JP; Foucher J; Bourlière M; Renou C; Tran A; Melin P; Hézode C; Chevalier M; Bouvier-Alias M; Chevaliez S; Montestruc F; Lonjon-Domanec I; Pawlotsky JM
Gastroenterology; 2006 Oct; 131(4):1040-8. PubMed ID: 17030174
[TBL] [Abstract][Full Text] [Related]
18. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.
Walsh MJ; Jonsson JR; Richardson MM; Lipka GM; Purdie DM; Clouston AD; Powell EE
Gut; 2006 Apr; 55(4):529-35. PubMed ID: 16299039
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
de Lucas S; Bartolome J; Carreno V
J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
